染色体结构重排携带者行PGT-SR的胚胎整倍体率与妊娠结局
相互易位组整倍体率最低,倒位组最高;罗氏易位女方携带者非整倍体率高于男方携带者。整倍体单囊胚移植后各组妊娠结局无显著差异。
要点
- 相互易位携带者整倍体率最低,倒位携带者最高。
- 罗氏易位女方携带者胚胎非整倍体率52.34%,高于男方携带者39.66%。
- 整倍体单囊胚移植后各组妊娠结局无显著差异。
核心结论
- 染色体结构重排类型显著影响胚胎整倍体率,相互易位最低、倒位最高。
- 结构重排主要影响重排相关染色体分离,对非重排相关染色体倍性无明显影响。
- 经PGT-SR筛选的整倍体胚胎移植后妊娠结局无显著差异。
主要发现
- 相互易位、罗氏易位和倒位组间胚胎整倍体率、嵌合体率、非整倍体率及衍生型、新发型、混合型非整倍体率差异均有统计学意义(P均<0.05)。
- 罗氏易位组中女方携带者胚胎非整倍体率52.34%,显著高于男方携带者39.66%(P<0.01)。
- 相互易位和罗氏易位组获得整倍体囊胚可能性低于PGT-M对照组(aOR=0.278,95%CI 0.237~0.327,P<0.01;aOR=0.569,95%CI 0.467~0.693,P<0.01),倒位组与对照组类似(aOR=1.080,95%CI 0.802~1.455,P=0.613)。
- 整倍体单囊胚冻融移植周期中,三组间子宫内膜准备方案、内膜厚度、生化妊娠率、临床妊娠率、自然流产率、持续妊娠率、异位妊娠率差异均无统计学意义(P均>0.05)。
关键数值与推荐
- 相互易位组胚胎整倍体率最低,倒位组最高。
- 罗氏易位女方携带者胚胎非整倍体率52.34%,男方携带者39.66%(P<0.01)。
临床怎么用
- 咨询时应告知不同结构重排类型胚胎整倍体率存在差异,相互易位携带者获得整倍体囊胚概率较低。
- 罗氏易位女方携带者胚胎非整倍体风险较高,可据此进行个体化胚胎检测与移植策略。
- 整倍体胚胎移植后妊娠结局与核型正常对照相当,PGT-SR可有效筛选可移植胚胎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective: To investigate the embryonic chromosomal status and pregnancy outcomes of carriers of chromosomal structural rearrangements undergoing preimplantation genetic testing for structural rearrangement (PGT-SR), and to analyze the influence of factors on PGT-SR results. Methods: A retrospective analysis was conducted on clinical data from 700 couples with chromosomal structural rearrangements [including reciprocal translocation (RecT), Robertsonian translocation (RobT), and inversion] who underwent PGT-SR at Northwest Women's and Children's Hospital between 2019 and 2024. A total of 3 471 blastocysts were biopsied. A control group of 261 couples (1 282 biopsied blastocysts) with normal karyotypes undergoing preimplantation genetic testing for monogenic disease (PGT-M) due to monogenic disorders, matched for female age during the same period, were selected. Differences in euploidy rates and pregnancy outcomes after PGT-SR were compared among different types of structural rearrangement carriers. Furthermore, factors such as carrier sex, female age, and chromosomal breakpoint location were analyzed on the influence of embryonic euploidy. Results: (1) No statistically significant differences were observed among the RecT, RobT, and inversion groups in terms of male age, female body mass index, smoking history of both partners, basal follicle stimulating hormone, antral follicle count, number of oocytes retrieved, mature oocytes, 2 pronucleus zygotes, blastocyst formation, or biopsiable blastocysts (all P>0.05). (2) Significant differences were found among the RecT, RobT, and inversion groups in euploidy rate, mosaic embryo rate, aneuploidy rate, and the rates of derivative, de novo, and mixed aneuploidies (all P<0.05). The RecT group had the lowest euploidy rate, while the inversion group had the highest. The mosaic embryo rate was relatively higher in the inversion group. No significant difference was observed in the rate of aneuploidies unrelated to parental structural rearrangements among the RecT, RobT, and inversion groups (P>0.05). (3) Subgroup analysis within the RobT group showed that when the male had normal chromosomes and the female was the carrier, the embryonic aneuploidy rate was significantly higher than when the female was normal and the male was the carrier (52.34% vs 39.66%; P<0.01). In the RecT and inversion groups, breakpoint location was not an independent risk factor for embryonic aneuploidy (P>0.05). (4) Multivariate analysis using generalized estimating equation logistic regression showed that the likelihood of obtaining a euploid blastocyst were significantly lower in the RecT and RobT groups compared to the PGT-M control group (aOR=0.278, 95%CI: 0.237-0.327, P<0.01; aOR=0.569, 95%CI: 0.467-0.693, P<0.01, respectively), whereas the inversion group was similar to the control group (aOR=1.080, 95%CI: 0.802-1.455; P=0.613). Compared with the RecT group, the likelihood of aneuploidies unrelated to parental structural rearrangements was similar in the RobT and inversion groups (aOR=0.914, 95%CI: 0.739-1.131, P=0.408; aOR=0.792, 95%CI: 0.578-1.085, P=0.146, respectively). (5) In euploid single blastocyst frozen embryo transfer cycles, no statistically significant differences were found among the RecT, RobT, and inversion groups in endometrial preparation protocol, endometrial thickness on transfer day, human chorionic gonadotropin positivity rate, clinical pregnancy rate, spontaneous miscarriage rate, ongoing pregnancy rate, or ectopic pregnancy rate (all P>0.05). Conclusions: The type of chromosomal structural rearrangement significantly affects the embryonic euploidy rate. Chromosomal structural rearrangements primarily affect the segregation of rearrangement-related chromosomes, with no significant impact on the ploidy status of unrelated chromosomes. Factors such as the sex of the rearrangement carrier and female age influence embryonic euploidy, with heterogeneity observed among different rearrangement types. No significant statistical differences in pregnancy outcomes are found after transplantation of euploid embryos selected by PGT-SR. 目的: 探讨染色体结构重排携带者行胚胎植入前染色体结构重排遗传学检测(PGT-SR)后的胚胎染色体倍性状态及妊娠结局,并分析携带者性别等因素对PGT-SR结果的影响。 方法: 回顾性分析2019年至2024年在西北妇女儿童医院接受PGT-SR的700对染色体结构重排[包括相互易位(RecT)、罗氏易位(RobT)和倒位]携带者夫妇的临床资料,共活检囊胚3 471个;另选取同期女方年龄匹配、夫妇双方染色体核型正常因单基因病接受胚胎植入前单基因病遗传学检测(PGT-M)检测的261对夫妇(共活检囊胚1 282个)作为对照组,比较不同类型染色体结构重排携带者行PGT-SR后的胚胎整倍体率及妊娠结局的差异,并进一步探讨携带者性别、女方年龄及染色体断裂点位置等因素对胚胎整倍性的影响。 结果: (1)RecT、RobT和倒位携带者之间男方年龄、女方体重指数、双方吸烟史、基础卵泡刺激素、窦卵泡数、获卵数、成熟卵数、双原核数、形成囊胚数、可活检囊胚数等指标差异均无统计学意义(P均>0.05)。(2)RecT、RobT和倒位携带者之间胚胎整倍体率、胚胎嵌合体率、胚胎非整倍体率以及衍生型、新发型、混合型非整倍体率的差异均有统计学意义(P均<0.05)。RecT携带者胚胎整倍体率最低,倒位者最高。胚胎嵌合体率倒位携带者最高。RecT、RobT和倒位携带者之间与亲代染色体结构重排无关的非整倍体率差异无统计学意义(P>0.05)。(3)亚组分析显示,RobT夫妇中当女方为携带者(男方染色体正常)时,其胚胎非整倍体率显著高于男方为携带者(女方染色体正常),分别为52.34%、39.66%(P<0.01);RecT及倒位携带者依据染色体断裂点位置分类分析显示,断裂点位置不是影响胚胎非整倍体发生的独立危险因素(P>0.05)。(4)采用广义估计方程logistic回归进行多因素分析显示,RecT及RobT携带者获得整倍体囊胚的可能性显著低于行PGT-M的对照组(aOR=0.278,95%CI为0.237~0.327,P<0.01;aOR=0.569,95%CI为0.467~0.693,P<0.01),而倒位携带者与对照组类似(aOR=1.080,95%CI为0.802~1.455,P=0.613)。相比于RecT,RobT及倒位携带者的与亲代染色体结构重排无关的非整倍体的发生可能性类似(aOR=0.914,95%CI为0.739~1.131,P=0.408;aOR=0.792,95%CI为0.578~1.085,P=0.146)。(5)RecT、RobT及倒位携带者之间整倍体单囊胚冻融移植周期中的子宫内膜准备方案、子宫内膜厚度、生化妊娠率、临床妊娠率、自然流产率、持续妊娠率、异位妊娠率的差异均无统计学意义(P均>0.05)。 结论: 不同染色体结构重排类型对胚胎整倍体率的影响存在显著差异;染色体结构重排主要影响重排相关染色体的分离,对非重排相关染色体的倍性状态无明显影响;夫妇中染色体结构重排携带者的性别、女方年龄等因素均影响胚胎整倍性,不同结构重排类型的胚胎整倍体率影响因素存在异质性;经PGT-SR筛选的整倍体胚胎移植后妊娠结局无显著差异。.
引用
- Cai H, Shi JZ, Bai HY, et al. [Embryo euploidy rates and pregnancy outcomes in carriers of chromosomal structural rearrangements undergoing preimplantation genetic testing]. Zhonghua Fu Chan Ke Za Zhi. 2026. PMID: 42477917. doi:10.3760/cma.j.cn112141-20251218-00615
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。